Immunogenicity, clinical efficacy and safety of additional second COVID-19 booster vaccines against Omicron and its subvariants: A systematic review.
Chenchula S, Chandra MB, Adusumilli MB, Ghanta SN, Bommasani A, Kuttiappan A, Padmavathi R, Amerneni KC, Chikatipalli R, Ghanta MK, Reddy SS, Mythili Bai K, Prakash S, Jogender G, Chavan M, Balakrishnan S.
Chenchula S, et al. Among authors: balakrishnan s.
Rev Med Virol. 2024 Jan;34(1):e2515. doi: 10.1002/rmv.2515.
Rev Med Virol. 2024.
PMID: 38282403
Review.